packageBrigatinib

brigatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Brigatinib is a protein kinase inhibitor used to treat non-small-cell lung carcinoma. It is authorised in the European Union for this cancer indication.

Summary written by glm-5.3-flash from Wikidata Q27456393 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:brigatinib
ATC codes:L01ED04, L01XE43
DrugBank:DB12267
PubChem CID:68165256
Wikidata:Q27456393
formula:C29H39ClN7O2P
molar mass:584.102 g/mol (PubChem CID 68165256)
logP:4.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown